Skip to main content
TipRanks
Go Ultimate75% OFF

Karyopharm Therapeutics (KPTI) Revenue

3 Followers

Karyopharm Therapeutics Revenue

Karyopharm Therapeutics had a revenue of 33.43M in the quarter ending Jun 30, 2026, with -4.66%. This bring the company's revenue in the last twelve months to 146.62M, Decreased 2.98%. In the fiscal year ending Dec 31, 2025, Karyopharm Therapeutics had annual revenue of 146.07M with 0.57% growth.

Revenue (ttm)
146.62M
Revenue Growth
―
P/S Ratio
0.00
Revenue/Employee
CHF 640,645
Employees
228
Market Cap
CHF 483.43K

Revenue Chart

Karyopharm Therapeutics Revenue - Annual

050M100M150M200M250M1.60M30.34M40.89M108.08M209.82M157.07M146.03M145.24M146.07M201720182019202020212022202320242025
Revenue History
Download to Excel
CH:KPTI revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 2025146.07M830.00K0.57%
Dec 31, 2024145.24M-796.00K-0.55%
Dec 31, 2023146.03M-11.04M-7.03%
Dec 31, 2022157.07M-52.74M-25.14%
Dec 31, 2021209.82M101.73M94.12%
Dec 31, 2020108.08M67.19M164.31%
Dec 31, 201940.89M10.56M34.80%
Dec 31, 201830.34M28.73M1790.09%
Dec 31, 20171.60M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
CH:KPTI146.62M
ATNM35.09M
LTRN0.00
IPSC0.00
MDCX0.00